SURG vs GLIBK
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 16, 2026
SURG
GLIBK
Investment Advisor Scores
GLIBK
AI Analyst Insights
Detailed Metrics Comparison
| Metric | SURG | GLIBK | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 15.1515 | 7.4516 | GLIBK |
| PEG Ratio | 0.5333 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 40.7% | 0.0% | SURG |
| Earnings Growth | -77.7% | -54.0% | GLIBK |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 50.1/100 | 54.8/100 | GLIBK |
| Profit Margin | -47.9% | -32.5% | GLIBK |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
SURG
MarkdownPrice below a falling SMA50 (slope -22.7%), weak momentum, RSI 35
GLIBK
NeutralMixed signals - no dominant trend phase, RSI 31
Fundamentals Snapshot
| Metric | SURG | GLIBK |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 12.7 | 7.5 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.4% | 0.0% |
| Gross Margin | -0.2% | 0.5% |
| Operating Margin | 0.2% | 0.1% |
| EPS | -1.50 | -11.10 |
| Dividend Yield | — | — |